PSS25 Actinic Keratosis Patients are Willing to Pay for Shorter Treatment and Local Skin Response Duration and Ingenol Mebutate Gel is Likely to Increase Patient Likelihood of Successful Completion of Topical Treatment [PDF]
Michael Willis+4 more
openalex +1 more source
New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel
Brian BermanUniversity of Miami Miller School of Medicine, Miami, and Center for Clinical and Cosmetic Research, Aventura, FL, USAAbstract: Actinic keratosis is a common disease in older, fair-skinned people, and is a consequence of cumulative ...
Berman B
doaj
Ingenol mebutate: a novel topical agent for actinic keratosis [PDF]
C.A. Morton
openalex +1 more source
Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling [PDF]
Sally R. Lambert+8 more
openalex +1 more source
Diagnosis and therapy of actinic keratosis
SummaryActinic keratosis (AK) is considered a chronic and recurring in situ skin neoplasia, with a possible transformation into invasive squamous cell carcinoma (SCC). Among others, predominant risk factors for development of AK are UV‐light exposure and immunosuppression. Basal epidermal keratinocyte atypia (AK I) and proliferation (PRO score) seem to
Janis Raphael Thamm+2 more
openaire +3 more sources
Clinical and morphological features actinic keratosis
The article presents the clinical and morphological characteristics of different variants of actinic keratosis in 20 patients. It was found that in 18 (90.0%) patients, lesions were localized exclusively to exposed skin areas (face, neck, and back of ...
O. Bondar
doaj +1 more source
A Cost-Effectiveness Analysis of Ingenol Mebutate Gel for the Treatment of Actinic Keratosis: A Scottish Perspective [PDF]
Keith Tolley+4 more
openalex +1 more source
The Profile Of The Actinic Keratosis (AK) Patients In The City Of São Paulo – Project Pilot [PDF]
A.raújo GTB+6 more
openalex +1 more source